Gemini Therapeutics (NASDAQ:GMTX) Sets New 12-Month High – Time to Buy?

Shares of Gemini Therapeutics, Inc. (NASDAQ:GMTX – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $66.90 and last traded at $65.00, with a volume of 255858 shares changing hands. The stock had previously closed at $66.18. Gemini Therapeutics Stock Down 1.8 % The firm […]

Leave a Reply

Your email address will not be published.

Previous post Short Interest in Costamare Inc. (NYSE:CMRE) Drops By 9.4%
Next post Federal judge allows Derek Chauvin’s counsel to obtain George Floyd tissue, fluid samples